BNB Plus Corp. splits its revenue into 8 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Jun 30, 2026 was Product at $585,551, 97% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Jun 30, 2026
|
Q3 FY2026
Jun 30, 2026
|
Q2 FY2026
Mar 31, 2026
|
Q1 FY2026
Dec 31, 2025
|
Q4 FY2025
Sep 30, 2025
|
Q3 FY2025
Jun 30, 2025
|
Q2 FY2025
Mar 31, 2025
|
Q1 FY2025
Dec 31, 2024
|
Q4 FY2024
Sep 30, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
0
|
| Product |
2
+70.6%
share 97.4%
|
1
+199.9%
share 96.7%
|
1
+83.7%
share 98.4%
|
1
+11.9%
share 98.2%
|
0
+44.4%
share 92.5%
|
0
share 64.1%
|
1
share 71.9%
|
0
share 57.0%
|
0
share 26.2%
|
| Large Scale Dna Production |
—
|
—
|
—
|
0
share 74.8%
|
0
+9.9%
share 59.0%
|
—
|
—
|
—
|
0
share 22.0%
|
| Clinical Laboratory Testing Services Over Time |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0
share 66.6%
|
| Supply Chain |
—
|
—
|
—
|
0
-84.3%
share 20.1%
|
0
-85.6%
share 19.6%
|
0
share 30.0%
|
—
|
1
share 83.1%
|
0
share 55.8%
|
| Research And Development Services |
—
|
—
|
—
|
0
-80.5%
share 5.1%
|
0
share 21.4%
|
0
share 17.1%
|
—
|
0
share 16.9%
|
—
|
| Services |
0
-94.2%
share 2.6%
|
0
-81.9%
share 3.3%
|
0
-92.4%
share 1.6%
|
0
-97.2%
share 1.8%
|
0
-95.8%
share 7.5%
|
0
share 35.9%
|
0
share 28.1%
|
0
share 43.0%
|
0
share 73.8%
|
| Clinical Laboratory Testing Services Point In Time |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0
share 0.2%
|
| Asset Marking |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
-0
share -0.0%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Finance Services (SIC 6199)
- Listed as
- BNBX (OTC)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Stony Brook, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 744452
- Former names
- APPLIED DNA SCIENCES INC (until Nov 10, 2025); PROHEALTH MEDICAL TECHNOLOGIES INC (until Dec 18, 2002); DCC ACQUISITION CORP (until May 4, 2001); DATALINK CAPITAL CORP/TX/ (until Feb 8, 1999)
Other Finance Services companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.